124
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Diminishing the side effect of mitomycin C by using pH-sensitive liposomes: in vitro characterization and in vivo pharmacokinetics

, &
Pages 159-169 | Published online: 15 Jan 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Kamel S. Ahmed, Saied A. Hussein, Abdelmoneim H. Ali, Sameh A. Korma, Qiu Lipeng & Chen Jinghua. (2019) Liposome: composition, characterisation, preparation, and recent innovation in clinical applications. Journal of Drug Targeting 27:7, pages 742-761.
Read now

Articles from other publishers (12)

Sharanya Kandula, Pravin Kumar Singh, Gun Anit Kaur & Ashutosh Tiwari. (2023) Trends in smart drug delivery systems for targeting cancer cells. Materials Science and Engineering: B 297, pages 116816.
Crossref
Mehrab Pourmadadi, Amirhossein Ghaemi, Meysam Shaghaghi, Negar Naderian, Fatemeh Yazdian, Abbas Rahdar & Luiz Fernando Romanholo Ferreira. (2023) Macromolecules and nanomaterials loaded with mitomycin C as promising new treatment option Cancer drug nanoformulation: A literature review. Journal of Drug Delivery Science and Technology 87, pages 104835.
Crossref
Mohammad Varzandeh, Jaleh Varshosaz, Sheyda Labbaf & Nafiseh Esmaeil. (2023) Sodium-borohydride exfoliated bismuthene loaded with Mitomycin C for chemo-photo-radiotherapy of triple negative breast cancer. International Journal of Pharmaceutics 636, pages 122825.
Crossref
Soheil Zabihi, Monireh Bakhshpour, Merve Çalışır, Aykut Arif Topçu & Adil Denizli. (2022) Preparation of molecular imprinted injectable polymeric micro cryogels for control release of mitomycin C. Polymer Bulletin 80:4, pages 3883-3895.
Crossref
Claudia Baron, Marie Buchholz, Britta Majchrzak-Stiller, Ilka Peters, Daniel Fein, Thomas Müller, Waldemar Uhl, Philipp Höhn, Johanna Strotmann & Chris Braumann. (2022) Substance GP-2250 as a New Therapeutic Agent for Malignant Peritoneal Mesothelioma—A 3-D In Vitro Study. International Journal of Molecular Sciences 23:13, pages 7293.
Crossref
Alexander R Vernon, Roy M Pemberton & H Ruth Morse. (2022) A novel in vitro 3D model of the human bone marrow to bridge the gap between in vitro and in vivo genotoxicity testing . Mutagenesis 37:2, pages 112-129.
Crossref
Disha N. Moholkar, Priyadarshani S. Sadalage, Darshana V. Havaldar & Kiran D. Pawar. (2021) Engineering the liposomal formulations from natural peanut phospholipids for pH and temperature sensitive release of folic acid, levodopa and camptothecin. Materials Science and Engineering: C 123, pages 111979.
Crossref
Jarno E.J. Wolters, Ralph J.S. van Mechelen, Rana Al Majidi, Leonard Pinchuk, Carroll A.B. Webers, Henny J.M. Beckers & Theo G.M.F. Gorgels. (2021) History, presence, and future of mitomycin C in glaucoma filtration surgery. Current Opinion in Ophthalmology 32:2, pages 148-159.
Crossref
Qiuxia Yang, Zhengyu Deng, Dan Wang, Jiaxuan He, Dailiang Zhang, Yan Tan, Tianhuan Peng, Xue-Qiang Wang & Weihong Tan. (2020) Conjugating Aptamer and Mitomycin C with Reductant-Responsive Linker Leading to Synergistically Enhanced Anticancer Effect. Journal of the American Chemical Society 142:5, pages 2532-2540.
Crossref
Sonali Pal-Ghosh, Gauri Tadvalkar, Verna Rose Lieberman, Xiaoqing Guo, James D. Zieske, Audrey Hutcheon & Mary Ann Stepp. (2019) Transient Mitomycin C-treatment of human corneal epithelial cells and fibroblasts alters cell migration, cytokine secretion, and matrix accumulation. Scientific Reports 9:1.
Crossref
Jacinta O Pinho, Joana D Amaral, Rui E Castro, Cecília MP Rodrigues, Angela Casini, Graça Soveral & Maria Manuela Gaspar. (2019) Copper complex nanoformulations featuring highly promising therapeutic potential in murine melanoma models. Nanomedicine 14:7, pages 835-850.
Crossref
Yu-Hsiang Lee & Yu-Chun Lin. (2018) Anti-EGFR Indocyanine Green-Mitomycin C-Loaded Perfluorocarbon Double Nanoemulsion: A Novel Nanostructure for Targeted Photochemotherapy of Bladder Cancer Cells. Nanomaterials 8:5, pages 283.
Crossref